neonatal%20jaundice
NEONATAL JAUNDICE
Jaundice that appears in a newborn <24 hour old is most likely nonphysiologic and needs further evaluation.
Jaundice typically presents on the 2nd-3rd day of life. It is usually first seen on the face and forehead then progresses caudally to the trunk and extremities.
Visible jaundice in the feet may be an indication to check bilirubin level.
Visual estimation of bilirubin level is often inaccurate and unreliable.
Danger signs in a newborn infant with jaundice includes changes in brainstem evoked auditory potentials, changes in muscle tone, seizures and altered cry characteristics.
The presence of any of the danger signs require prompt attention to prevent kernicterus.

Definition

  • Yellowish discoloration of the skin and sclera in infants < 28 days old due to the accumulation of serum bilirubin levels of >85 µmol/L (>5 mg/dl)
  • Jaundice typically presents on the 2nd-3rd day of life

Physiologic jaundice

  • More common in breastfed than in bottlefed neonates
  • Occurs in neonates <14 days old
  • Caused by an abrupt increase in bilirubin load of the liver after birth
  • May extend beyond 14 days in term infants & >21 days in preterm infants

Pathologic jaundice

  • Occurs in neonates >14 days old
  • Caused by underlying diseases such as ABO incompatibility, sepsis, liver disease, glucose-6-phosphate dehydrogenase deficiency, metabolic disorders
  • May develop into kernicterus if the following are present:
    • Signs of acute bilirubin encephalopathy present
    • Increasing serum bilirubin of >8.5 µmol/L/hour
    • Gestational age >37 weeks with serum bilirubin of >340 µmol/L

Etiology

Possible Causes of Jaundice

Unconjugated Hyperbilirubinemia

  • Hemolysis resulting from ABO blood group incompatibility, infection, red blood cell (RBC) membrane defects (eg G6PD deficiency), RBC enzyme defects, hemoglobinopathies
  • Physiologic jaundice which results from increased bilirubin production brought about by accelerated destruction of RBCs, decreased excretory capacity secondary to low levels of ligandin in hepatocytes, & low activity of the bilirubin-conjugating enzyme uridine diphosphate glucuronyltransferase (UDPGT)
  • Breastfeeding which may give rise to decreased bilirubin clearance
  • Polycythemia, bruising, internal hemorrhage, mutations of glucuronyltransferase, infant of mother with diabetes

Conjugated Hyperbilirubinemia

  • Neonatal hepatitis, sepsis, TORCH infection, urinary tract infection
  • Rare: Biliary atresia, inborn errors of metabolism

Signs and Symptoms

  • Danger signs in a newborn infant with jaundice:
    • Changes in brainstem evoked auditory potentials (eg decreased amplitude, prolonged latencies)
    • Changes in muscle tone
    • Seizures
    • Altered cry characteristics
  • The above findings require prompt attention to prevent kernicterus

Risk Factors

Risk factors for severe hyperbilirubinemia in infants >35 wk of gestation

  • Jaundice observed in the first 24 hour of life
  • Total Serum Bilirubin (TSB) & Transcutaneous Bilirubinometry (TcB) in high-risk zone
  • Blood group incompatibility
  • Cephalohematoma or significant bruising
  • Sibling who received phototherapy
  • Exclusive breastfeeding
  • Gestational age 35-36 week
  • East Asian race as defined by mother’s description
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
one year ago
Adjunct boceprevir is  effective for patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-genotype-1 coinfection unresponsive to pegylated interferon/ribavarin (PEGIFN/RBV) therapy, as shown in a retrospective study.
Saras Ramiya, 2 years ago
Women with intrahepatic cholestasis of pregnancy (ICP) face a higher risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life, shows a study conducted in Sweden.
Dr. Mohd Ismail Merican, 2 years ago
Chronic hepatitis B (CHB) has a worldwide distribution; 2 billion people, or one third of the world’s population, are infected.
one year ago
Based on an 8-week prospective study, L-carnitine is effective and safe in reducing muscle cramps in patients with cirrhosis.